Doubt greets reports of suramin’s promise for treating autism
The boys who received the drug showed modest improvements in autism features relative to the five boys in the control group. However, the study was not designed to assess the drug’s effectiveness. The rash may have tipped off the parents as to whether their child was in the treatment or control group — and may have contributed to a placebo effect.
View Full ArticleYou need to login or register to bookmark/favorite this content.